Skip to main content
    N

    Nano X Imaging Ltd (NNOX)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NASDAQ

    $0.32
    -0.00 (-0.56%)

    Market Cap: $25.36M

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Nano X Imaging Ltd (NNOX) Financials: Revenue, Profit and Cash Flow

    Updated Jul 20, 2026. Financial statements from company filings, amounts in US dollars.

    Nano X Imaging reported revenue of $13.02M for the fiscal year ended Dec 31, 2025, up 15.4% from the year before. That year, net income was -$75.02M with a net margin of -576.1%, operating cash flow was -$40.79M and free cash flow was -$45.00M. The quarter ended Jun 30, 2026 had revenue of $4.16M and net income of -$55.49M.

    Revenue and Margins

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Dec 2025$13.02M+15.4%-98.2%-466.2%-576.1%
    Dec 2024$11.28M+13.9%-94.0%-502.9%-474.3%
    Dec 2023$9.90M+15.5%-66.6%-631.9%-613.6%
    Dec 2022$8.58M+557.8%-80.2%-1279.0%-1226.9%
    Dec 2021$1.30MN/A-116.0%-4720.7%-4739.1%
    Dec 2020$0N/AN/AN/AN/A
    Dec 2019$0N/AN/AN/AN/A
    Dec 2018$0N/AN/AN/AN/A
    Annual, fiscal years ended Dec 2018 to Dec 2025

    Income Statement

    In the fiscal year ended Dec 2025, the net loss widened from the year before. In the quarter ended Jun 2026, the net loss widened from the same quarter a year earlier.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
    Revenue$13.02M$11.28M$9.90M$8.58M$1.30M$0$0$0
    Cost of revenue$25.81M$21.89M$16.50M$15.46M$2.82M$208.00K$53.00K$35.00K
    Gross profit-$12.79M-$10.61M-$6.59M-$6.88M-$1.51M-$208.00K-$53.00K-$35.00K
    Research and development$19.24M$20.18M$26.05M$26.51M$17.12M$9.21M$2.72M$672.00K
    Operating income-$60.70M-$56.75M-$62.59M-$109.71M-$61.56M-$43.92M-$22.57M-$1.90M
    Net income-$75.02M-$53.52M-$60.78M-$105.24M-$61.80M-$43.50M-$22.55M-$1.91M
    EBITDA-$49.00M-$45.01M-$47.69M-$75.70M-$59.27M-$43.72M-$22.52M-$1.87M
    Fiscal years ended Dec 2018 to Dec 2025

    Quarterly

    Line itemJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Revenue$4.16M$4.31M$3.72M$3.45M$3.04M$2.81M$3.00M$3.03M$2.70M$2.55M$2.40M$2.48M
    Gross profit-$43.67M-$2.70M-$3.91M-$2.88M-$3.24M-$3.05M-$2.89M-$2.81M-$2.85M-$2.15M-$1.72M-$1.66M
    Operating income-$55.48M-$14.79M-$16.50M-$14.23M-$14.49M-$14.09M-$14.97M-$14.14M-$14.51M-$13.08M-$13.26M-$21.99M
    Net income-$55.49M-$14.27M-$33.37M-$13.68M-$14.72M-$13.24M-$14.06M-$13.64M-$13.57M-$12.24M-$10.25M-$21.40M
    Last 12 quarters

    Balance Sheet

    As of Dec 2025, cash and equivalents exceeded short-term debt of $4.09M by $45.06M.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
    Total assets$162.16M$210.00M$218.65M$253.93M$363.17M$236.15M$11.87M$1.85M
    Current assets$66.79M$78.68M$88.64M$82.46M$94.86M$219.79M$9.64M$1.70M
    Cash and equivalents$49.15M$39.30M$56.38M$38.46M$66.64M$213.47M$8.07M$5.00K
    Total liabilities$22.43M$20.88M$23.13M$37.25M$71.02M$5.40M$20.65M$8.24M
    Short-term debt$4.09M$3.81M$4.35M$740.00K$1.03M$519.00K$140.00KN/A
    Long-term debtN/AN/AN/A$3.48M$3.80MN/AN/AN/A
    Shareholder equity$139.73M$189.12M$195.51M$216.68M$292.15M$230.75M-$8.78M-$6.38M
    Fiscal years ended Dec 2018 to Dec 2025

    Quarterly

    Line itemJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total assets$91.19M$145.77M$162.16M$176.09M$184.23M$196.74M$210.00M$183.94M$195.72M$205.88M$218.65M$231.31M
    Total liabilities$18.72M$19.46M$22.43M$19.38M$20.67M$19.57M$20.88M$20.05M$20.59M$20.92M$23.13M$29.28M
    Cash and equivalents$31.02M$43.85M$49.15M$45.19M$49.90M$40.37M$39.30M$38.19M$38.98M$44.97M$56.38M$66.38M
    Shareholder equity$72.47M$126.31M$139.73M$156.71M$163.56M$177.16M$189.12M$163.89M$175.13M$184.96M$195.51M$202.03M
    Last 12 quarters

    Cash Flow

    Operating cash flow was negative in the fiscal year ended Dec 2025.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
    Operating cash flow-$40.79M-$36.60M-$44.78M-$43.38M-$38.07M-$21.49M-$5.52M-$3.67M
    Capital expenditures$4.21M$2.77M$3.30M$7.17M$23.16M$13.94M$125.00K$73.00K
    Free cash flow-$45.00M-$39.37M-$48.08M-$50.56M-$61.23M-$35.42M-$5.65M-$3.74M
    Investing cash flow$29.37M-$20.05M$35.43M$14.61M-$116.32M-$13.94M-$125.00K-$73.00K
    Financing cash flow$21.37M$39.50M$27.25M$804.00K$7.38M$240.99M$13.86M$3.68M
    Fiscal years ended Dec 2018 to Dec 2025

    Quarterly

    Line itemJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Operating cash flow-$11.59M-$13.95M-$11.50M-$10.74M-$9.31M-$10.33M-$10.53M-$8.13M-$8.49M-$9.45M-$11.96M-$11.47M
    Capital expenditures$984.00K$1.78M$991.54K$1.74M$1.05M$527.00K$1.04M$734.00K$855.00K$141.00K$499.58K$936.00K
    Free cash flow-$12.58M-$15.73M-$12.49M-$12.48M-$10.36M-$10.85M-$11.57M-$8.86M-$9.35M-$9.59M-$12.46M-$12.41M
    Last 12 quarters

    Frequently Asked Questions About NNOX

    What is Nano X Imaging's annual revenue?

    Nano X Imaging reported revenue of $13.02M for the fiscal year ended Dec 31, 2025.

    How fast is Nano X Imaging's revenue growing?

    Revenue was up 15.4% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was 14.9%.

    Is Nano X Imaging profitable?

    No. Nano X Imaging reported net income of -$75.02M for the fiscal year ended Dec 31, 2025, with a net margin of -576.1%.

    How much free cash flow does NNOX generate?

    For the fiscal year ended Dec 31, 2025, operating cash flow of -$40.79M minus capital expenditures of $4.21M produced free cash flow of -$45.00M.

    How much debt does Nano X Imaging have?

    The balance sheet dated Dec 31, 2025 reported short-term debt of $4.09M and cash and equivalents of $49.15M.